Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

The Lancet

Volumn 374, Issue 9697, 2009, Pages 1252-1261

  Gilron, Ian ^a,b   Bailey, Joan M ^a,b   Tu, Dongsheng ^a   Holden, Ronald R ^a   Jackson, Alan C ^c   Houlden, Robyn L ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; NORTRIPTYLINE; OPIATE; PARACETAMOL;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; ATAXIA; BLURRED VISION; CANADA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHAGIA; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERHIDROSIS; INSOMNIA; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MENTAL CONCENTRATION; MENTAL INSTABILITY; MONOTHERAPY; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

EID: 70349766844     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61081-3     Document Type: Article

References (37)

1. Merskey H., and Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd edn. (1994), IASP Press, Seattle, WA 212
2. Hall G.C., Carroll D., Parry D., and McQuay H.J. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122 (2006) 156-162
3. Bouhassira D., Lantéri-Minet M., Attal N., Laurent B., and Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136 (2008) 380-387
4. Treede R.D., Jensen T.S., Campbell J.N., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70 (2008) 1630-1635
5. Berger A., Dukes E.M., and Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5 (2004) 143-149
6. Turk D.C. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 18 (2002) 355-365
7. Dworkin R.H., O'Connor A.B., Backonja M., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 (2007) 237-251
8. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
9. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 (2005) 1324-1334
10. Field M.J., Cox P.J., Stott E., et al. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 103 (2006) 17537-17542
11. Max M.B., and Gilron I. Antidepressants, muscle relaxants, and NMDA receptor antagonists. In: Loeser J.D., Turk D., Chapman C.R., and Butler S. (Eds). Bonica's management of pain. 3rd edn. (2001), Williams & Wilkins, Philadelphia, PA
12. Heughan C.E., and Sawynok J. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration. Anesth Analg 94 (2002) 975-980
13. Freynhagen R., Strojek K., Griesing T., Whalen E., and Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115 (2005) 254-263
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 suppl 1 (2005) S37-S42
15. Dworkin R.H., Turk D.C., Farrar J.T., et al., IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113 (2005) 9-19
16. Cleeland C.S., and Ryan K.M. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23 (1994) 129-138
17. Melzack R. The short-form McGill pain questionnaire. Pain 30 (1987) 191-197
18. Ware J.E., Snow K.K., Kosinski M.A., and Gandek M.S. SF-36 health survey manual and interpretation guide (1997), Nimrod Press, Boston, MA
19. Beck A.T., and Steer R.A. Beck depression inventory manual (1993), The Psychological Corporation, San Antonio, TX
20. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
21. Jones B., and Kenward M.G. Design and analysis of cross-over trials. 2nd edn. (2003), Chapman & Hall/CRC, Boca Raton, FL
22. Hochberg Y., and Tamhane A.C. Multiple comparison procedures (1987), Wiley, New York, NY
23. Agresti A. Categorical data analysis (1990), Wiley, New York, NY
24. Morello C.M., Leckband S.G., Stoner C.P., Moorhouse D.F., and Sahagian G.A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159 (1999) 1931-1937
25. Galer B.S., Gianas A., and Jensen M.P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47 (2000) 123-128
26. Raja S.N., and Haythornthwaite J.A. Combination therapy for neuropathic pain-which drugs, which combination, which patients?. N Engl J Med 352 (2005) 1373-1375
27. Rice A.S., and Hill R.G. New treatments for neuropathic pain. Annu Rev Med 57 (2006) 535-551
28. Gilron I., and Max M.B. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 5 (2005) 823-830
29. Juniper E.F., Jenkins C., Price M.J., and James M.H. Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma. Am J Respir Med 1 (2002) 435-440
30. Law M.R., Wald N.J., Morris J.K., and Jordan R.E. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326 (2003) 1427
31. Lilenbaum R.C., Langenberg P., and Dickersin K. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival. Cancer 82 (1998) 116-126
32. Graff-Radford S.B., Shaw L.R., and Naliboff B.N. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 16 (2000) 188-192
33. Khoromi S., Cui L., Nackers L., and Max M.B. Morphine, nortriptyline and their combination vs placebo in patients with chronic lumbar root pain. Pain 130 (2007) 66-75
34. Tallarida R.J. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 319 (2006) 1-7
35. Rintala D.H., Holmes S.A., Courtade D., Fiess R.N., Tastard L.V., and Loubser P.G. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil 88 (2007) 1547-1560
36. Harden C.L., Lazar L.M., Pick L.H., et al. A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 40 (1999) 1129-1134
37. Chandra K., Shafiq N., Pandhi P., Gupta S., and Malhotra S. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial-the GONIP Trial. Int J Clin Pharmacol Ther 44 (2006) 358-363